Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 11/2009

01-11-2009 | Article

The effect of Bacillus subtilis mouth rinsing in patients with periodontitis

Authors: S. Tsubura, H. Mizunuma, S. Ishikawa, I. Oyake, M. Okabayashi, K. Katoh, M. Shibata, T. Iizuka, T. Toda, T. Iizuka

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 11/2009

Login to get access

Abstract

Bacillus subtilis is an effective probiotic product for prevention of enteric infections both in humans and animals. We hypothesized that a mouth rinse containing Bacillus subtilis should adhere to and colonize part of the oral bacteria on periodontal tissue. The rinsing ability of Extraction 300E (containing Bacillus subtilis: E-300 ) was compared with that of a mouth wash liquid , Neosteline Green (benzethonium chloride; NG) that is commonly used in Japan. Compared with NG rinsing, E-300 rinsing resulted in a marked change in the BANA-score. The mean BANA values (score ± SD) over the course of the study from 0 to 30 days were 1.52 ± 0.51 (p ≤ 0.1) and 0.30 ± 0.47 (p ≤ 0.01) for E-300, and 1.56 ± 0.51 and 0.93 ± 0.68 for NG, respectively. Gingival Index also had improvement, while probing pocket depth and bleeding on probing showed small improvements. Mouth rinsing with E-300 significantly reduced periodontal pathogens compared with NG. These results suggest that Bacillus subtilis is an appropriate mouth rinse for patients with periodontitis.
Literature
1.
go back to reference Nishimura F, Iwamoto Y, Mineshiba J et al (2003) Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-alpha in a 2-way relationship. J Periodontol 74:97–102CrossRefPubMed Nishimura F, Iwamoto Y, Mineshiba J et al (2003) Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-alpha in a 2-way relationship. J Periodontol 74:97–102CrossRefPubMed
2.
go back to reference Becker W, Becker BE, Caffesse R et al (2001) A longitudinal study comparing scaling, osseous surgery, and modified Widman procedures: results after 5 years. J Periodontol 72:1675–1684CrossRefPubMed Becker W, Becker BE, Caffesse R et al (2001) A longitudinal study comparing scaling, osseous surgery, and modified Widman procedures: results after 5 years. J Periodontol 72:1675–1684CrossRefPubMed
3.
go back to reference van Winkelhoff AJ, Rams TE, Slots J (1996) Systemic antibiotic therapy in periodontics. Periodontol 10:45–78 2000CrossRef van Winkelhoff AJ, Rams TE, Slots J (1996) Systemic antibiotic therapy in periodontics. Periodontol 10:45–78 2000CrossRef
4.
go back to reference Slots J, Rams TE (1990) Antibiotics in periodontal therapy: advantages and disadvantages. J Clin Periodontol 17(7(Pt 2)):479–493 Slots J, Rams TE (1990) Antibiotics in periodontal therapy: advantages and disadvantages. J Clin Periodontol 17(7(Pt 2)):479–493
5.
go back to reference Ciancio SG, Lauciello F, Shibly O et al (1995) The effect of an antiseptic mouthrinse on implant maintenance: Plaque and peri-implant gingival tissues. J Periodontol 66:962–965PubMed Ciancio SG, Lauciello F, Shibly O et al (1995) The effect of an antiseptic mouthrinse on implant maintenance: Plaque and peri-implant gingival tissues. J Periodontol 66:962–965PubMed
6.
go back to reference Christine H, Charles RDH, Naresh C et al (2001) Comparative efficacy of an antiseptic mouthrinse and an antiplaque/antigingivitis dentifrice. J Am Dent Assoc 132:670–675 Christine H, Charles RDH, Naresh C et al (2001) Comparative efficacy of an antiseptic mouthrinse and an antiplaque/antigingivitis dentifrice. J Am Dent Assoc 132:670–675
7.
go back to reference Charles CH, Mostler KM, Bartels LL et al (2004) Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. J Clin Periodontol 31:878–884CrossRefPubMed Charles CH, Mostler KM, Bartels LL et al (2004) Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. J Clin Periodontol 31:878–884CrossRefPubMed
8.
go back to reference Meurman JH (2005) Probiotics: do they have a role in oral medicine and dentistry? Eur J Oral Sci 113:188–196CrossRefPubMed Meurman JH (2005) Probiotics: do they have a role in oral medicine and dentistry? Eur J Oral Sci 113:188–196CrossRefPubMed
9.
go back to reference Newaj-Fyzul A, Adesiyun AA, Mutani A et al (2007) Bacillus subtilis AB1 controls Aeromonas infection in rainbow trout (Oncorhynchus mykiss, Walbaum). J Appl Microbiol 103:1699–1706CrossRefPubMed Newaj-Fyzul A, Adesiyun AA, Mutani A et al (2007) Bacillus subtilis AB1 controls Aeromonas infection in rainbow trout (Oncorhynchus mykiss, Walbaum). J Appl Microbiol 103:1699–1706CrossRefPubMed
10.
go back to reference Brunt J, Newaj-Fyzul A, Austin B (2007) The development of probiotics for the control of multiple bacterial diseases of rainbow trout, Oncorhynchus mykiss (Walbaum). J Fish Dis 30:573–579CrossRefPubMed Brunt J, Newaj-Fyzul A, Austin B (2007) The development of probiotics for the control of multiple bacterial diseases of rainbow trout, Oncorhynchus mykiss (Walbaum). J Fish Dis 30:573–579CrossRefPubMed
11.
go back to reference Loe H, Silness J (1963) Periodontal disease in pregnancy.1. Prevalence and severity. Acta Odontologica Scandinavica 21:533–551CrossRefPubMed Loe H, Silness J (1963) Periodontal disease in pregnancy.1. Prevalence and severity. Acta Odontologica Scandinavica 21:533–551CrossRefPubMed
12.
go back to reference Loesche WJ, Bretz WA, Lopatin D et al (1990) Multi-center clinical evaluation of a chairside method for detecting certain periodontopathic bacteria in periodontal disease. J Periodontol 61:189–196PubMed Loesche WJ, Bretz WA, Lopatin D et al (1990) Multi-center clinical evaluation of a chairside method for detecting certain periodontopathic bacteria in periodontal disease. J Periodontol 61:189–196PubMed
13.
go back to reference Hong HA, le Duc H, Cutting SM (2005) The use of bacterial spore formers as probiotics. FEMS Microbiol Rev 29:813–835CrossRefPubMed Hong HA, le Duc H, Cutting SM (2005) The use of bacterial spore formers as probiotics. FEMS Microbiol Rev 29:813–835CrossRefPubMed
14.
go back to reference Wang J, Fung DY (1996) Alkaline-fermented foods: a review with emphasis on pidan fermentation. Crit Rev Microbiol 22:101–138CrossRefPubMed Wang J, Fung DY (1996) Alkaline-fermented foods: a review with emphasis on pidan fermentation. Crit Rev Microbiol 22:101–138CrossRefPubMed
15.
go back to reference de Jong N, Ocké MC, Branderhorst HA et al (2003) Demographic and lifestyle characteristics of functional food consumers and dietary supplement users. Br J Nutr 89:273–281CrossRefPubMed de Jong N, Ocké MC, Branderhorst HA et al (2003) Demographic and lifestyle characteristics of functional food consumers and dietary supplement users. Br J Nutr 89:273–281CrossRefPubMed
16.
17.
go back to reference Hatakka K, Ahola AJ, Yli-Knuuttila H et al (2007) Probiotics reduce the prevalence of oral candida in the elderly–a randomized controlled trial. J Dent Res 86:125–130CrossRefPubMed Hatakka K, Ahola AJ, Yli-Knuuttila H et al (2007) Probiotics reduce the prevalence of oral candida in the elderly–a randomized controlled trial. J Dent Res 86:125–130CrossRefPubMed
18.
go back to reference Krasse P, Carlsson B, Dahl C et al (2006) Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swed Dent J 30:55–60PubMed Krasse P, Carlsson B, Dahl C et al (2006) Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swed Dent J 30:55–60PubMed
Metadata
Title
The effect of Bacillus subtilis mouth rinsing in patients with periodontitis
Authors
S. Tsubura
H. Mizunuma
S. Ishikawa
I. Oyake
M. Okabayashi
K. Katoh
M. Shibata
T. Iizuka
T. Toda
T. Iizuka
Publication date
01-11-2009
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 11/2009
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-009-0790-9

Other articles of this Issue 11/2009

European Journal of Clinical Microbiology & Infectious Diseases 11/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine